The MAO Inhibitor Tranylcypromine Alters LPS- and Aβ-Mediated Neuroinflammatory Responses in Wild-type Mice and a Mouse Model of AD

Monoamine oxidase (MAO) has been implicated in neuroinflammation, and therapies targeting MAO are of interest for neurodegenerative diseases. The small-molecule drug tranylcypromine, an inhibitor of MAO, is currently used as an antidepressant and in the treatment of cancer. However, whether tranylcy...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, HyunHee, Han, Kyung-Min, Jeon, Hyongjun, Lee, Ji-Soo, Lee, Hyunju, Jeon, Seong Gak, Park, Jin-Hee, Kim, Yu Gyung, Lin, Yuxi, Lee, Young-Ho, Jeong, Yun Ha, Hoe, Hyang-Sook
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7563969/
https://www.ncbi.nlm.nih.gov/pubmed/32872335
http://dx.doi.org/10.3390/cells9091982

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7563969/
https://www.ncbi.nlm.nih.gov/pubmed/32872335
http://dx.doi.org/10.3390/cells9091982

Ejemplares similares